After bullying allegations, Lander will return to the Broad; why the new competition for Humira matters

After nearly a year of public silence and private speculation over Eric Lander's next act, his return to the Broad is now official. 

January 27, 2023 Check out STAT+

Sponsored By

Josh Reynolds/AP STAT+ | After bullying allegations, Eric Lander will return to run a lab at the Broad Institute The Broad's director said Lander is "committed to upholding" the genomics research center's "inclusive culture of respect." By Megan Molteni STAT+ | A bellwether for biosimilars: Why the new competition for Humira matters to pharma, payers, and patients The first biosimilars for Humira are about to hit the market. Here's why that matters for drugmakers, payers, and patients. By Ed Silverman It's easy to buy flavored vapes in California, even in cities with longtime bans California cities are supposed to be cracking down on sales of flavored vapes, which are now illegal across the state. By Nicholas Florko Charlie Neibergall/AP FDA eases rules again for gay men seeking to donate blood The proposed change would do away with the current three-month abstinence requirement for donations from men who have sex with men. By Matthew Perrone — Associated Press STAT+ | Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination A U.K. pharmaceutical industry trade group ruled on a complaint that Pfizer CEO Albert Bourla's remarks on Covid-19 vaccines for kids. By Ed Silverman Opinion: How a checklist can help decolonize global health research The Douala Equity Checklist can help assure that global health research will benefit all partners, in low- and high-income countries. By Yap Boum II and Sunil Parikh Adobe STAT+ | Legend says its CAR-T outperformed conventional therapy for multiple myeloma The data from Legend add to a broader push by drugmakers to move cellular therapies into earlier lines of care. By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser